Calendar Laboratorios Farmaceuticos Rovi, S.A.

Equities

ROVI

ES0157261019

Pharmaceuticals

Market Closed - BME Other stock markets 11:35:07 2024-12-05 am EST			Pre-market 01:32:03 am
63.75 ^EUR	+0.79%		63.40	-0.55%

Nov. 07	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
Nov. 07	Laboratorios Farmaceuticos Rovi, S.A., Nine Months 2024 Earnings Call, Nov 07, 2024

Chart calendar Laboratorios Farmaceuticos Rovi, S.A.

1ff79226593323e49bc6025.doAAGJWrNJHCr5nrjgw0B8PPmqsXmiKAxaV4Pi6h6D0.OtY4SaTJU_W6-Omo92BWa_r-rMYv6VvQnfpPdGzvgg8pykxqptp3_qTpwA~4a5d65996432bd642d7619551f570287

Upcoming events on Laboratorios Farmaceuticos Rovi, S.A.

2025-03-03	Q4 2024 Earnings Release (Projected)
2025-05-06	Q1 2025 Earnings Release (Projected)
2025-08-04	Q2 2025 Earnings Release (Projected)
2025-11-05	Q3 2025 Earnings Release (Projected)

Past events on Laboratorios Farmaceuticos Rovi, S.A.

2024-11-07 04:00 am	Q3 2024 Earnings Call
2024-11-06	Q3 2024 Earnings Release Pre-market
2024-07-31 05:00 am	Q2 2024 Earnings Call
2024-07-30	Q2 2024 Earnings Release Pre-market
2024-07-07	Détachement de for final dividend
2024-05-07	Q1 2024 Earnings Call
2024-05-07	Q1 2024 Earnings Release Pre-market
2024-02-27 09:00 am	Q4 2023 Earnings Call
2024-02-26	Q4 2023 Earnings Release Pre-market
2023-11-07	Q3 2023 Earnings Call
2023-11-07	Q3 2023 Earnings Release Pre-market
2023-07-26 09:00 am	Q2 2023 Earnings Call
2023-07-25	Q2 2023 Earnings Release Pre-market
2023-07-02	Détachement de for final dividend
2023-06-14 05:00 am	Annual General Meeting
2023-05-09	Q1 2023 Earnings Call
2023-05-09	Q1 2023 Earnings Release Pre-market
2023-02-21 04:00 am	FY 2022 Earnings Call
2023-02-20	FY 2022 Earnings Release Pre-market
2022-11-23 04:00 am	Capital Market Day

Past dividends on Laboratorios Farmaceuticos Rovi, S.A.

2024-07-07	Annual 0.893997 EUR
2023-07-02	Annual 1.047978 EUR
2022-07-04	Annual 0.774036 EUR
2021-07-04	Annual 0.308772 EUR
2020-11-16	Annual 0.141831 EUR
2019-07-01	Annual 0.064638 EUR
2018-07-02	Annual 0.097767 EUR
2017-07-02	Annual 0.14823 EUR
2016-06-29	Annual 0.11259 EUR
2015-07-01	Annual 0.1352 EUR
2014-07-02	Annual 0.127348 EUR
2013-07-02	Annual 0.107914 EUR
2012-07-03	Annual 0.100251 EUR
2011-07-05	Annual 0.1393848 EUR
2010-07-05	Annual 0.11421 EUR
2009-07-07	Final Payment 0.07093 EUR
2008-09-16	Interim Payment 0.0642 EUR

Annual results

Fiscal Period	Diciembre	2021	2022	2023	2024	2025	2026
Net sales Million EUR	Released Forecast Spread	649 633 2.52%	818 788 3.78%	830 823 0.79%	788	792	936
EBITDA Million EUR	Released Forecast Spread	203 193 5.23%	279 252 10.47%	245 239 2.36%	236	248	327
EBIT Million EUR	Released Forecast Spread	181 171 5.95%	256 230 11.48%	220 214 2.67%	210	220	297
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	183 171 7.03%	258 226 14.07%	220 217 1.8%	208	214	301
Net income Million EUR	Released Forecast Spread	153 140 9.42%	200 183 9.36%	170 167 2.05%	163	173	233
EPS EUR	Released Forecast Spread	2,76 2,51 10.05%	3,73 3,35 11.19%	3,20 3,12 2.58%	3,11	3,34	4,49
Announcement Date		23/02/22	21/02/23	27/02/24	-

Quarterly results

Fiscal Period	Junio	2022 Q4	2023 Q1	2023 Q2	2023 S1	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 S1	2024 Q3
Net sales Million EUR	Released Forecast Spread	242 223 8.67%	202 195 3.15%	179 174 3.01%	381 377 1.02%	214 208 3.05%	235 226 3.91%	151 154 -1.55%	178 175 2.1%	329 327 0.81%	235 230 2.39%
EBITDA Million EUR	Released Forecast Spread	105 82,1 27.71%	66,5 59,1 12.57%	30,6 24,2 26.62%	97,1 93,0 4.41%	74,1 66,8 10.93%	73,3 71,1 3.14%	25,9 26,3 -1.33%	44,0 39,7 10.9%	69,9 67,7 3.25%	97,3 83,5 16.56%
EBIT Million EUR	Released Forecast Spread	99,0 74,5 32.91%	60,7 52,8 14.91%	24,5 19,0 28.98%	85,2 81,0 5.19%	68,2 58,5 16.58%	66,7 66,0 1.06%	19,3 20,6 -6.18%	37,2 32,4 14.76%	56,5 54,5 3.63%	90,1 79,5 13.36%
Earnings before Tax (EBT) Million EUR	Released Forecast Spread		61,2 55,3 10.67%					19,0 19,8 -4%
Net income Million EUR	Released Forecast Spread	78,2 59,8 30.82%	47,5 42,3 12.29%	19,1 13,6 40.1%	66,6 63,0 5.71%	52,2 45,5 14.77%	51,5 47,7 8.04%	15,0 11,9 25.37%	29,4 26,2 12.05%	44,3 41,9 5.84%	69,1 59,3 16.61%
Announcement Date		21/02/23	10/05/23	26/07/23	26/07/23	08/11/23	27/02/24	08/05/24	31/07/24	31/07/24	07/11/24

Upcoming sector events for Laboratorios Farmaceuticos Rovi, S.A.

2024-12-10 11:45 am	MEDINCELL S.A.: Q2 2025 Earnings Release
2025-01-08	HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2025 Earnings Release
2025-01-12	TILRAY BRANDS, INC.: Q2 2025 Earnings Release (Projected)
2025-01-20	AARTI PHARMALABS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21	AARTI DRUGS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21	ALEMBIC PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21	JOHNSON & JOHNSON: Q4 2024 Earnings Release
2025-01-22	GLENMARK LIFE SCIENCES LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-27	GRANULES INDIA LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-28	MANKIND PHARMA LIMITED: Q3 2025 Earnings Release (Projected)

More events

Past sector events for Laboratorios Farmaceuticos Rovi, S.A.

2024-12-04 02:06 am	CALIWAY BIOPHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release
2024-11-28	DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release
2024-11-15 01:38 am	BAVARIAN NORDIC A/S: Q3 2024 Earnings Release
2024-11-14 11:01 pm	CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release
2024-11-14 09:03 am	GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release
2024-11-14 07:00 am	OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release
2024-11-14 02:49 am	IPCA LABORATORIES LIMITED: Q2 2025 Earnings Release
2024-11-14 01:30 am	DERMAPHARM HOLDING SE: Q3 2024 Earnings Release
2024-11-14 01:30 am	ALK-ABELLÓ A/S: Q3 2024 Earnings Release
2024-11-13	DONGKOOK PHARMACEUTICAL CO., LTD.: Q3 2024 Earnings Release